Pular para o conteúdo
Merck
  • Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery.

Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery.

Bioorganic & medicinal chemistry (2008-05-09)
Anneli Nordqvist, Mikael T Nilsson, Svenja Röttger, Luke R Odell, Wojciech W Krajewski, C Evalena Andersson, Mats Larhed, Sherry L Mowbray, Anders Karlén
RESUMO

A combination of a literature survey, structure-based virtual screening and synthesis of a small library was performed to identify hits to the potential antimycobacterial drug target, glutamine synthetase. The best inhibitor identified from the literature survey was (2S,5R)-2,6-diamino-5-hydroxyhexanoic acid (4, IC(50) of 610+/-15microM). In the virtual screening 46,400 compounds were docked and subjected to a pharmacophore search. Of these compounds, 29 were purchased and tested in a biological assay, allowing three novel inhibitors containing an aromatic scaffold to be identified. Based on one of the hits from the virtual screening a small library of 15 analogues was synthesized producing four compounds that inhibited glutamine synthetase.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
L-Methionine sulfone
Sigma-Aldrich
L-Homoserine
Sigma-Aldrich
DL-5-Hydroxylysine hydrochloride
Sigma-Aldrich
L-(+)-2-Amino-4-phosphonobutyric acid, optical purity optical purity: ≥95% (HPLC, Marfey′s reagent)
Sigma-Aldrich
L-Homocysteic acid, ≥95%